Brain and Behavior Influences on Obesity Development From Infancy Through Childhood
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: fMRI cue reactivity task, fMRI go no go task, Ad libitum meal test, Eating in the absence of hunger test.
- Who it may be relevant to
- Registry conditions: Obesity and Overweight. Basic parameters: 7 years — 12 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Early Brain Development and Child Nutrition and Obesity
Overview
The investigators project, RESONATE, aims to investigate why some children develop obesity. To do this it uses data on eating and eating-related behaviors, genetic and environmental factors, and brain structure and function. This data is collected in a sub-sample of RESONANCE, a large study of families of children from infancy through childhood. The results will lay foundations for the development of early interventions to prevent or treat obesity.
Detailed description
Obesity risk shows individual variation such that some children are more likely than others to gain excess weight. One potential reason is that, due to genetic and environmental factors, individuals vary in appetitive behaviors that drive food intake and weight. However, the neurodevelopmental mechanisms underpinning variation in appetite and weight, and effects of risk and protective factors on those outcomes, are not understood. Preliminary data from RESONANCE, the investigators large MRI cohort, suggests obesity risk factors such as maternal pre-pregnancy obesity and obesity-associated genetic variants are associated with not just heightened parent-reported child appetite and adiposity, but with altered patterns of brain structure development from infancy through early childhood. However the relevance of these findings to appetitive behaviors and development of obesity in middle childhood is unknown. This is important because obesity rates and metabolic complications increase through development, adiposity and eating habits measured in later childhood track into adulthood, and obesity is harder to treat later in development, making middle childhood a key stage for capturing outcomes with relevance for lifetime metabolic health. Further, although functional magnetic resonance imaging (MRI) studies have identified altered patterns of activation in brain appetite circuits in association with pediatric obesity and early risk factors for obesity, the predictors of altered functioning of brain appetite circuits in middle childhood are unknown. Identifying the patterns of brain development that predict obesity-promoting behaviors and brain functioning in middle childhood is essential to understand the neural mechanisms by which early obesity risk factors drive excess intake and obesity, and may help pinpoint neurobehavioral targets for early obesity prevention. Finally, although preclinical research and MRI studies of children under 9 years of age support that hypothalamic gliosis, a cellular inflammatory response, plays a role in obesity pathogenesis, it is unclear whether it occurs or impacts appetite in earlier life. For the proposed study, RESONATE, the investigators will address the above research gaps by extending the RESONANCE study to administer meal tests, behavioral and functional magnetic resonance imaging (fMRI) tasks assessing food and non-food reward and cognitive control, and weight/ adiposity measures in middle childhood, and examining hypothalamic gliosis, in a sub-sample of RESONANCE children. By combining this data with extant MRI data and extant or newly-collected data on obesity risk and protective factors, the investigators will test a multi-faceted hypothesis that prenatal, genetic and postnatal factors lead to differential early development of brain appetite circuits, which in turn gives rise to variation in appetitive behaviors and behaviors involving reward processing and cognitive control as well as altered function of brain appetite circuits, that act to influence the development of obesity into middle childhood. The investigator's long-term goal is to lay foundations for developmentally-appropriate, neurobehaviorally-informed interventions to address child obesity.
Interventions
- Other fMRI cue reactivity task
Measures effect of food and non-food cues on brain activation - Other fMRI go no go task
Measures effect of food and non-food cues on inhibitory responses and brain activation - Other Ad libitum meal test
Measures effect of exposure to multi-item buffet meal on food intake - Other Eating in the absence of hunger test
Measures effect of exposure to palatable snacks on food intake
Primary outcome measures
- Meal test intake as assessed by total kilocalories consumed [Time frame: Day 1]
- Weight/adiposity as assessed by BMI [Time frame: Day 1]
- Food-related reward as assessed by food-related delay discounting task [Time frame: Day 1]
- Food-related cognitive control as assessed by food-related go/no-go task [Time frame: Day 1]
- Functioning in brain appetite circuits as assessed by cue reactivity task [Time frame: During MRI procedure]
- Functioning in brain appetite circuits as assessed by cognitive control task [Time frame: During MRI procedure]
Eligibility criteria
Inclusion criteria
- Participants from the RESONANCE cohort are eligible if the participant will reach 7-12 years of age during the proposed project period and have no food allergies.
Exclusion criteria
- Exclusion criteria for RESONANCE include:
- In utero exposure to alcohol, cigarette, or illicit substances;
- First trimester fetal US abnormalities;
- Complicated pregnancy (e.g., pre-eclampsia);
- Complicated delivery, including APGAR scores less than 8 and/or neonatal intensive care unit (NICU) admission;
- History of neurological (e.g., epilepsy), psychiatric (e.g., anxiety or depression requiring treatment with medication) or developmental disorder (e.g., autism spectrum disorder (ASD), dyslexia);
- Contraindications for MRI including metal in the body, claustrophobia.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Basic science
Study locations
United States · 4 centers
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc. — Baltimore
- Johns Hopkins University School of Medicine — Baltimore
- Rhode Island Hospital — Providence
- University of Washington — Seattle
Identifiers
NCT: NCT06861868 · IRB00118376 · R01DK136602